Literature DB >> 9271286

Evaluation of a protocol to select patients of all ages for cardioversion from atrial fibrillation.

P J Lawson-Matthew1, A Ionescu, P McHugh, K S Channer.   

Abstract

OBJECTIVE: to audit the success of a decision protocol to select patients for cardioversion from atrial fibrillation or flutter by recording the success of cardioversion and the maintenance of sinus rhythm over a 2-year period.
DESIGN: retrospective case notes review.
SETTING: a teaching hospital coronary care unit and cardiology department. PATIENTS: 227 consecutive patients were considered for cardioversion from atrial fibrillation or flutter from 1989 to 1992; 128 fulfilled the selection criteria. MAIN OUTCOME MEASURES: successful cardioversion and maintenance of sinus rhythm after cardioversion.
RESULTS: 116 (91%) patients selected by application of the guidelines were successfully cardioverted. The probabilities of maintaining sinus rhythm at 6, 12 and 24 months were 0.92, 0.88 and 0.73 respectively.
CONCLUSION: careful selection of patients in atrial fibrillation identifies a group in whom cardioversion is likely to be safe and successful regardless of age.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271286     DOI: 10.1093/ageing/26.4.247

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  4 in total

1.  Managing atrial fibrillation in elderly people.

Authors:  K M English; K S Channer
Journal:  BMJ       Date:  1999-04-24

2.  Determinants of successful direct current cardioversion for atrial fibrillation and flutter: the importance of rapid referral.

Authors:  A R Houghton; A Sharman; J E Pohl
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

Review 3.  Current management of symptomatic atrial fibrillation.

Authors:  K S Channer
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Atrial fibrillation in the elderly: facts and management.

Authors:  Guy Chatap; Karine Giraud; Jean-Pierre Vincent
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.